NCT02018172View on ClinicalTrials.gov

Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device

TerminatedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Growth Hormone DeficiencyTurner's Syndrome
Interventions
DRUG

somatropin

Trial Locations (1)

Unknown

Hôpital des Enfants, CHU de Toulouse, Toulouse

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY